This communication shall not constitute an offer to sell or the solicitation of an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offering of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended.
VaxGen, Raven and their respective directors and executive officers may
be deemed to be participants in the solicitation of proxies from the
stockholders of VaxGen in connection with the merger transaction.
Information regarding the special interests of these directors and
executive officers in the merger transaction is included in the proxy
statement/prospectus described above. Additional information regarding the
directors and executive officers of VaxGen is also included in VaxGen's
definitive proxy statement for its 2007 Annual Meeting of Stockholders
which was filed with the SEC on November 21, 2007 and its Annual Report on
Form 10-K for the year ended December 31, 2006, which was filed with the
SEC on August 30, 2007.
|SOURCE VaxGen Inc.|
Copyright©2008 PR Newswire.
All rights reserved